Jakab, Á., Kovács, F., Balla, N., Nagy-Köteles, C., Ragyák, Á., Nagy, F., Borman, A., Majoros, L., Kovács, R.: Comparative transcriptional analysis of Candida auris biofilms following farnesol and tyrosol treatment.
Microbiol. Spectr. 12 (4), 1-12, 2024.

Kovács, F., Balla, N., Bozó, A., Harmath, A., Jakab, Á., Tóth, Z., Nagy, F., Majoros, L., Kovács, R.: Epidemiology, clinical characteristics, outcome and biofilm forming properties in candidaemia: a single-centre retrospective 4-year analysis from Hungary.
Mycoses. 67 (4), 1-12, 2024.

Spengler, G., Gajdács, M., Donadu, M., Usai, M., Marchetti, M., Ferrari, M., Mazzarello, V., Zanetti, S., Nagy, F., Kovács, R.: Evaluation of the Antimicrobial and Antivirulent Potential of Essential Oils Isolated from Juniperus oxycedrus L. ssp. macrocarpa Aerial Parts.
Microorganisms. 10 (4), 1-20, 2022.

Kovács, R., Tóth, Z., Locke, J., Forgács, L., Kardos, G., Nagy, F., Borman, A., Majoros, L.: Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum.
Microorganisms. 9 (4), 1-12, 2021.

Nagy, F., Tóth, Z., Váradi, G., Tóth, L., Forgács, L., Vadászi, K., Majoros, L., Galgóczy, L., Kovács, R.: Echinocandinok és a Neosartorya fischeri antifungális fehérje 2 (NFAP2) kombinációjának in vitro vizsgálata Candida auris biofilmek ellen.
Acta Microbiol. Immunol. Hung. 68 28-29, 2021.

Nagy, F., Tóth, Z., Nyikos, F., Forgács, L., Jakab, Á., Borman, A., Majoros, L., Kovács, R.: In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.
Med. Mycol. 59 (10), 1015-1023, 2021.

Balázs, B., Nagy, J., Tóth, Z., Nagy, F., Károlyi, S., Turcsányi, I., Bistyák, A., Kálmán, A., Sárközi, R., Kardos, G.: Occurrence of Escherichia coli producing extended spectrum [béta]-lactamases in food-producing animals.
Acta Vet. Hung. 69 (3), 1-5, 2021.

Jakab, Á., Emri, T., Csillag, K., Szabó, A., Nagy, F., Baranyai, E., Sajtos, Z., Géczi, D., Antal, K., Kovács, R., Szabó, K., Dombrádi, V., Pócsi, I.: The negative effect of protein phosphatase Z1 deletion on the oxidative stress tolerance of Candida albicans is synergistic with betamethasone exposure.
J. Fungi. 7 (540), 1-24, 2021.

Kovács, R., Nagy, F., Tóth, Z., Forgács, L., Tóth, L., Váradi, G., Tóth, G., Vadászi, K., Borman, A., Majoros, L., Galgóczy, L.: The Neosartorya fischeri Antifungal Protein 2 (NFAP2): a New Potential Weapon against Multidrug-Resistant Candida auris Biofilms.
Int. J. Mol. Sci. 22 (2), 1-14, 2021.

Balázs, B., Tóth, Z., Nagy, F., Kovács, R., Tóth, H., Nagy, J., Tóth, Á., Szarka, K., Majoros, L., Kardos, G.: The Role of Uniform Meropenem Usage in Acinetobacter baumannii Clone Replacement.
Antibiotics. 10 (2), 1-12, 2021.

Jakab, Á., Balla, N., Ragyák, Á., Nagy, F., Kovács, F., Sajtos, Z., Tóth, Z., Borman, A., Pócsi, I., Baranyai, E., Majoros, L., Kovács, R.: Transcriptional profiling of the Candida auris response to exogenous farnesol exposure.
mSphere. 6 (5), 1-12, 2021.

Kovács, R., Jakab, Á., Ragyák, Á., Sajtos, Z., Nagy, F., Baranyai, E., Pócsi, I., Majoros, L.: Transcriptomic approaches for the farnesol exposure of Candida auris.
Acta Microbiol. Immunol. Hung. 68 85, 2021.

Vitális, E., Nagy, F., Tóth, Z., Forgács, L., Bozó, A., Kardos, G., Majoros, L., Kovács, R.: Candida biofilm production is associated with higher mortality in patients with candidaemia.
Mycoses. 63 (4), 352-360, 2020.

Nemes, D., Kovács, R., Nagy, F., Tóth, Z., Herczegh, P., Borbás, A., Kelemen, V., Pfliegler, V., Rebenku, I., Hajdu, P., Fehér, P., Ujhelyi, Z., Fenyvesi, F., Váradi, J., Vecsernyés, M., Bácskay, I.: Comparative biocompatibility and antimicrobial studies of sorbic acid derivates.
Eur. J. Pharm. Sci. 143 1-9, 2020.

Forgács, L., Borman, A., Prépost, E., Tóth, Z., Kardos, G., Kovács, R., Székely, A., Nagy, F., Kovács, I., Majoros, L.: Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model.
Emerg. Microbes Infect. 9 (1), 1160-1169, 2020.

Nagy, F., Vitális, E., Jakab, Á., Borman, A., Forgács, L., Tóth, Z., Majoros, L., Kovács, R.: In vitro and in vivo effect of exogenous farnesol exposure against Candida auris.
Front. Microbiol. 11 1-12, 2020.

Tóth, Z., Forgács, L., Kardos, T., Kovács, R., Locke, J., Kardos, G., Nagy, F., Borman, A., Adnan, A., Majoros, L.: Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species.
J. Fungi. 6 (3), 1-9, 2020.

Tóth, Z., Forgács, L., Locke, J., Kardos, G., Nagy, F., Kovács, R., Borman, A., Majoros, L.: Comparison of killing activity of rezafungin, anidulafungin, caspofungin and micafungin against Candida auris in the presence and absence of serum.
J. Fungi. 5 (95), 130-131, 2019.

Prépost, E., Tóth, Z., Perlin, D., Gesztelyi, R., Kardos, G., Kovács, R., Nagy, F., Forgács, L., Majoros, L.: Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis.
Infect Drug Resist. 12 1805-1814, 2019.

Nagy, F., Tóth, Z., Daróczi, L., Székely, A., Borman, A., Majoros, L., Kovács, R.: Farnesol increases the activity of echinocandins against Candida auris biofilms.
Med. Mycol. 58 (3), 404-407, 2019.

Nagy, F., Tóth, Z., Bozó, A., Czeglédi, A., Rebenku, I., Majoros, L., Kovács, R.: Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.
Med. Mycol. 57 (5), 573-581, 2019.

Forgács, L., Tóth, Z., Locke, J., Nagy, F., Balázs, B., Prépost, E., Kardos, G., Kovács, R., Székely, A., Borman, A., Majoros, L.: Frequency of paradoxical and trailing effects with rezafungin, anidulafungin, caspofungin and micafungin against Candida species.
J. Fungi. 5 (95), 131-132, 2019.

Tóth, Z., Forgács, L., Locke, J., Kardos, G., Nagy, F., Kovács, R., Székely, A., Borman, A., Majoros, L.: In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae.
J. Antimicrob. Chemother. 74 (12), 3505-3510, 2019.

Jakab, Á., Tóth, Z., Nagy, F., Nemes, D., Bácskay, I., Kardos, G., Emri, T., Pócsi, I., Majoros, L., Kovács, R.: Physiological and transcriptional response of Candida parapsilosis to exogenous tyrosol.
Appl. Environ. Microbiol. 85 (20), 1-12, 2019.

Kovács, R., Nagy, F., Tóth, Z., Bozó, A., Balázs, B., Majoros, L.: Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
Lett. Appl. Microbiol. 69 (4), 271-278, 2019.

Nagy, F., Tóth, Z., Forgács, L., Borman, A., Majoros, L., Balázs, B., Kovács, R.: The effect of farnesol on Candida auris biofilms, virulence and azole susceptibility.
J. Fungi. 95 (5), 141-142, 2019.

Kovács, R., Nagy, F., Tóth, Z., Majoros, L.: The effect of nikkomycin Z in combination with echinocandins against Candida albicans and Candida parapsilosis biofilms.
Acta Microbiol. Immunol. Hung. 66 56-57, 2019.

Kovács, R., Jakab, Á., Tóth, Z., Nagy, F., Emri, T., Pócsi, I., Majoros, L.: Transcriptional and physiological effect exerted by tyrosol on Candida parapsilosis cells.
J. Fungi. 5 (95), 142-143, 2019.

Tóth, Z., Kardos, T., Kovács, R., Kardos, G., Nagy, F., Prépost, E., Barta, Z., Takács, I., Majoros, L.: Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum.
Mycopathologia. 183 (6), 905-912, 2018.

Nemes, D., Kovács, R., Nagy, F., Mező, M., Poczok, N., Ujhelyi, Z., Pető, Á., Fehér, P., Fenyvesi, F., Váradi, J., Vecsernyés, M., Bácskay, I.: Interaction between Different Pharmaceutical Excipients in Liquid Dosage Forms: assessment of Cytotoxicity and Antimicrobial Activity.
Molecules. 23 (7), 1-19, 2018.

Nagy, F., Bozó, A., Tóth, Z., Daróczi, L., Majoros, L., Kovács, R.: In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates.
Med. Mycol. 56 (4), 493-500, 2018.

Kardos, T., Kovács, R., Kardos, G., Varga, I., Bozó, A., Tóth, Z., Nagy, F., Majoros, L.: Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results.
J. Chemother. 30 (4), 233-239, 2018.

Kovács, R., Nagy, F., Tóth, Z., Bozó, A., Majoros, L.: The effect of human serum on the efficacy of traditional antifungals against Candida albicans and Candida parapsilosis biofilms.
Med. Mycol. 56 S131, 2018.

Jakab, Á., Nagy, F., Tóth, Z., Nemes, D., Majoros, L., Bácskay, I., Pócsi, I., Kovács, R.: Tyrosol influences the physiology and virulence of Candida parapsilosis.
In: Fiatal Biotechnológusok Országos Konferenciája. Szerk.: Tamás László, Zelenyánszki Helga, JATEPress, Szeged, 95, 2018. ISBN: 9789633153703

Kovács, R., Tóth, Z., Nagy, F., Daróczi, L., Bozó, A., Majoros, L.: Activity of exogenous tyrosol in combination with caspofungin and micafungin against Candida parapsilosis sessile cells.
J. Appl. Microbiol. 122 (6), 1529-1536, 2017.

Kovács, R., Nagy, F., Bozó, A., Tóth, Z., Daróczi, L., Kardos, G., Majoros, L.: The in vitro susceptibility pattern of C. kefyr planktonic cells and biofilms against traditional antifungal agents.
Acta Microbiol. Immunol. Hung. 62 152, 2017.

Kovács, R., Bozó, A., Gesztelyi, R., Domán, M., Kardos, G., Nagy, F., Tóth, Z., Majoros, L.: Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
Int. J. Antimicrob. Agents. 47 (4), 304-310, 2016.

Kovács, R., Bozó, A., Nagy, F., Tóth, Z., Majoros, L.: The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
Acta Microbiol. Immunol. Hung. 64 16, 2016.

Kovács, R., Bozó, A., Domán, M., Nagy, F., Tóth, Z., Majoros, L.: Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
Mycoses. 58 79-80, 2015.